VACCIN TIFOIDIC SUBCUTANAT 5x100 mil.-1mld./0.5ml injection suspension INCDMI CANTACUZINO
Chemical substance: cellular inactivated typhoid vaccine
ATC code: J07AP02 • Antiinfectives for systemic use | Bacterial vaccines | Typhoid vaccines
Active substance
Results for the substance cellular inactivated typhoid vaccine
1 result
About this active substance
The inactivated whole-cell typhoid vaccine is used to prevent typhoid fever, a bacterial disease caused by Salmonella typhi. This vaccine contains inactivated (killed) bacteria that stimulate the immune system to produce antibodies against the bacteria, providing protection against infection.
The vaccine is administered intramuscularly, usually in a single dose, and is recommended for individuals traveling to endemic areas or those at increased risk of infection. The protection provided by the vaccine lasts approximately 2-3 years, and revaccination is necessary to maintain immunity.
Common side effects include pain at the injection site, mild fever, fatigue, and muscle aches. In rare cases, severe allergic reactions may occur.
The inactivated whole-cell typhoid vaccine is an important preventive measure for reducing the incidence of typhoid fever, particularly in regions with poor sanitation and limited access to safe drinking water.
The vaccine is administered intramuscularly, usually in a single dose, and is recommended for individuals traveling to endemic areas or those at increased risk of infection. The protection provided by the vaccine lasts approximately 2-3 years, and revaccination is necessary to maintain immunity.
Common side effects include pain at the injection site, mild fever, fatigue, and muscle aches. In rare cases, severe allergic reactions may occur.
The inactivated whole-cell typhoid vaccine is an important preventive measure for reducing the incidence of typhoid fever, particularly in regions with poor sanitation and limited access to safe drinking water.